Osteogenic promotion by naringin through the PI3K/AKT/mTOR pathway-mediated activation of autophagy and inhibition of apoptosis
Bone · 2026
DOI: 10.1016/j.bone.2026.117958 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bone, 2026. Verfasst von Yubo Cui und 6 weiteren Autor:innen. Beteiligte Einrichtung: Jiangxi University of Chinese Medicine, Nanchang, 330000, Jiangxi, China. Hauptthemen laut MEDLINE: Flavanones, Autophagy, Apoptosis, Proto-Oncogene Proteins c-akt. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Jiangxi Provincial Natural Science Foundation.
Abstract (Originalsprache)
Osteoporosis is a common age-related metabolic bone disease closely associated with osteoblast dysfunction, abnormal apoptosis, and dysregulated autophagy. Naringin, a dihydroflavonoid compound mainly found in citrus fruits and various traditional Chinese medicinal herbs (e.g., Aurantii Fructus Immaturus and Rhizoma Drynariae), exhibits potential anti-aging and osteoprotective effects; however, its specific mechanism requires systematic elucidation. Network pharmacology analysis revealed that the core targets of naringin are significantly enriched in the PI3K/AKT signaling pathway, as well as pathways related to apoptosis and autophagy. Subsequent in vitro experiments demonstrated that naringin promotes osteoblast proliferation, differentiation, and mineralization; upregulates the expression of osteogenic markers; activates protective autophagy; and inhibits apoptosis. By employing the autophagy inhibitor 3-MA and the PI3K/AKT agonist 740Y-P to modulate PI3K/AKT/mTOR-mediated autophagy, we confirmed that the anti-apoptotic effect of naringin is dependent on the activation of autophagy. In vivo, naringin administration inhibited the excessive activation of the PI3K/AKT/mTOR pathway, enhanced autophagy, suppressed excessive apoptosis, ameliorated bone microarchitecture, and increased bone mineral density in ovariectomized mice. Our findings elucidate the mechanism by which naringin exerts its anti-osteoporotic effects through regulating the balance between autophagy and apoptosis, thereby providing a theoretical basis for developing naringin-based anti-aging strategies for bone protection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiangxi University of Chinese Medicine, Nanchang, 330000, Jiangxi, China.
- Jiangxi University of Chinese Medicine, Nanchang, 330000, Jiangxi, China; The First Affiliated Hospital of Lishui University, China.
- Jiangxi University of Chinese Medicine, Nanchang, 330000, Jiangxi, China; Affiliated Hospital of Jiangxi University of Chinese Medicine, Nanchang, 330000, Jiangxi, China.
- Affiliated Hospital of Jiangxi University of Chinese Medicine, Nanchang, 330000, Jiangxi, China.
- Affiliated Hospital of Jiangxi University of Chinese Medicine, Nanchang, 330000, Jiangxi, China. Electronic address: yfy_jxszyy@126.com.
Förderung
- Jiangxi Provincial Natural Science Foundation
Zitieren
APA
Cui, Y., Yu, G., Li, D., Fu, X., Yang, Z., Yang, W., & Yang, F. (2026). Osteogenic promotion by naringin through the PI3K/AKT/mTOR pathway-mediated activation of autophagy and inhibition of apoptosis. Bone. https://doi.org/10.1016/j.bone.2026.117958
Vancouver
Cui Y, Yu G, Li D, Fu X, Yang Z, Yang W, et al. Osteogenic promotion by naringin through the PI3K/AKT/mTOR pathway-mediated activation of autophagy and inhibition of apoptosis. Bone. 2026. doi:10.1016/j.bone.2026.117958
BibTeX
@article{Cui2026,
author = {Cui, Yubo and Yu, Guisong and Li, Dian and Fu, Xing and Yang, Zhijun and Yang, Wenlong and Yang, Fengyun},
title = {Osteogenic promotion by naringin through the PI3K/AKT/mTOR pathway-mediated activation of autophagy and inhibition of apoptosis},
journal = {Bone},
year = {2026},
doi = {10.1016/j.bone.2026.117958}
}
EUVIMED